Cytokinetics's three largest insider shareholders as of March 23, 2026 are Robert I Blum (President Ceo, 391.67K shares), David Cragg (Chief Hr Admin Officer, 153.23K shares), Fady Ibraham Malik (Evp Research Development, 138.63K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Robert I Blum | President Ceo | 430,330 | 0 | 18 Mar, 2026 |
| Fady Ibraham Malik | Evp Research Development | 153,902 | 0 | 18 Mar, 2026 |
| David Cragg | Chief Hr Admin Officer | 153,233 | 0 | 08 Mar, 2022 |
| Jeffrey Hessekiel | Chief Legal Admin Officer | 107,943 | 0 | 17 Mar, 2026 |
| Mark A Schlossberg | Svp Legal General Counsel | 103,408 | 0 | 15 Mar, 2022 |
| Ching Jaw | Svp Finance Cfo | 87,346 | 0 | 07 Mar, 2023 |
| Sung Lee | Evp, Chief Financial Officer | 87,127 | 0 | 18 Mar, 2026 |
| Andrew Callos | Evp, Chief Commercial Officer | 78,185 | 0 | 18 Mar, 2026 |
| John T Henderson | 74,912 | 0 | 16 Jan, 2026 | |
| Brett A Pletcher | Evp, Chief Legal Officer | 33,140 | 0 | 03 Sep, 2024 |
| Wendell Wierenga | 32,542 | 0 | 16 Jan, 2026 | |
| Wendall Wierenga | 32,345 | 0 | 16 Jul, 2025 | |
| Nancy Wysenski | 30,971 | 0 | 16 Jan, 2026 | |
| L Patrick Gage | 28,932 | 0 | 08 Nov, 2021 | |
| Sandford D Smith | 18,801 | 0 | 03 Jan, 2024 | |
| Robert Arthur Harrington | 18,739 | 0 | 16 Jan, 2026 | |
| Robert Wong | Vp, Chief Accounting Officer | 18,655 | 0 | 05 Dec, 2024 |
| B Lynne Parshall | 17,933 | 0 | 02 Mar, 2026 | |
| Edward M. Md Kaye | 10,174 | 0 | 16 Jan, 2026 | |
| Robert E Landry | 7,333 | 0 | 14 May, 2025 | |
| Robert Califf | 6,003 | 0 | 04 Jan, 2022 | |
| James M Daly | 197 | 0 | 20 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Mar, 2026 | Andrew Callos | Common Stock | D | 5,626 | $62.15 | 74,489 | D | S |
| 18 Mar, 2026 | Andrew Callos | Common Stock | D | 1,930 | $62.07 | 78,185 | D | S |
| 17 Mar, 2026 | Robert I Blum | Common Stock | D | 12,673 | $62.15 | 454,258 | D | S |
| 17 Mar, 2026 | Sung Lee | Common Stock | D | 4,935 | $62.15 | 87,127 | D | S |
| 17 Mar, 2026 | Fady Ibraham Malik | Common Stock | D | 7,636 | $62.15 | 158,299 | D | S |
| 17 Mar, 2026 | Andrew Callos | Common Stock | D | 2,916 | $62.15 | 71,573 | D | S |
| 17 Mar, 2026 | Robert I Blum | Common Stock | D | 23,928 | $62.15 | 430,330 | D | S |
| 17 Mar, 2026 | Fady Ibraham Malik | Common Stock | D | 4,397 | $62.15 | 153,902 | D | S |
| 15 Mar, 2026 | Sung Lee | Common Stock | A | 20,646 | $0.00 | 92,062 | D | A |
| 15 Mar, 2026 | Andrew Callos | Common Stock | A | 20,646 | $0.00 | 68,504 | D | A |
| 15 Mar, 2026 | Fady Ibraham Malik | Common Stock | A | 27,306 | $0.00 | 165,935 | D | A |
| 15 Mar, 2026 | Jeffrey Hessekiel | Common Stock | A | 20,646 | $0.00 | 107,943 | D | A |
| 15 Mar, 2026 | Robert I Blum | Common Stock | A | 75,258 | $0.00 | 466,931 | D | A |
| 15 Mar, 2026 | Sung Lee | Incentive Stock Option (Right to Buy) | A | 1,665 | $0.00 | 1,665 | D | A |
| 15 Mar, 2026 | Jeffrey Hessekiel | Incentive Stock Option (Right to Buy) | A | 8,325 | $0.00 | 8,325 | D | A |
| 15 Mar, 2026 | Andrew Callos | Common Stock | A | 13,320 | $0.00 | 81,824 | D | A |
| 15 Mar, 2026 | Fady Ibraham Malik | Incentive Stock Option (Right to Buy) | A | 1,665 | $0.00 | 1,665 | D | A |
| 15 Mar, 2026 | Fady Ibraham Malik | Non-Qualified Stock Option (Right to Buy) | A | 39,527 | $0.00 | 39,527 | D | A |
| 15 Mar, 2026 | Sung Lee | Non-Qualified Stock Option (Right to Buy) | A | 29,480 | $0.00 | 29,480 | D | A |
| 15 Mar, 2026 | Andrew Callos | Incentive Stock Option (Right to Buy) | A | 1,665 | $0.00 | 1,665 | D | A |